| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500369 | Farmacia Hospitalaria | 2009 | 9 Pages |
Abstract
The use of darbepoetin alpha for the treatment of chronic renal failure induced anaemia (haemodialysis and pre-dialysis) shows higher cost efficiency than epoetin alpha in Spain; these differences increase with IV administration.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
A. Sanz-Granda,